PROTAC BCR-ABL Degrader-1
PROTAC BCR-ABL Degrader-1 is a heterobifunctional molecule that induces targeted degradation of the Bcr-Abl oncoprotein via the ubiquitin-proteasome system. It demonstrates potent anti-proliferative activity in K562 chronic myeloid leukemia cells in vitro, making it a valuable chemical tool for investigating targeted protein degradation in oncology research.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Molecular Formula
C43H40N10O6
Molecular Weight
792.84
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0199-24V 50 µg
KRT19, ID (Keratin, Type I Cytoskeletal 19, Cytokeratin-19, CK-19, Keratin-19, K19) discontinued
Sign In for Pricing
View Details 
MBS6147456-01 0.1 mL
Granzyme B (C11, CTLA-1, Cathepsin G-like 1, CTSGL1, Cytotoxic T-lymphocyte Proteinase 2, Lymphocyte Protease, Fragmentin-2, Granzyme-2, Human Lymphocyte Protein, HLP, SECT, T-cell Serine Protease 1-3E, GZMB, CGL1, CSPB, CTLA1, GRB) (FITC)
Sign In for Pricing
View Details